Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors

The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie 2022-07, Vol.134 (28), p.e202203662-n/a
Hauptverfasser: Torrente‐Rodríguez, Rebeca M., Montero‐Calle, Ana, San Bartolomé, Clara, Cano, Olga, Vázquez, Mónica, Iglesias‐Caballero, María, Corral‐Lugo, Andrés, McConnell, Michael J., Pascal, Mariona, Mas, Vicente, Pingarrón, José M., Barderas, Rodrigo, Campuzano, Susana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 28
container_start_page e202203662
container_title Angewandte Chemie
container_volume 134
creator Torrente‐Rodríguez, Rebeca M.
Montero‐Calle, Ana
San Bartolomé, Clara
Cano, Olga
Vázquez, Mónica
Iglesias‐Caballero, María
Corral‐Lugo, Andrés
McConnell, Michael J.
Pascal, Mariona
Mas, Vicente
Pingarrón, José M.
Barderas, Rodrigo
Campuzano, Susana
description The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection. A multiplexed amperometric bioplatform can detect and quantify total and isotype N‐ and S‐specific anti‐SARS‐CoV‐2 serum immunoglobulins within 75 minutes. The platform was used to analyze the global and isotype‐specific immune response of COVID‐19 convalescent and vaccinated individuals, and to detect variant‐specific S antibodies from variants of concern.
doi_str_mv 10.1002/ange.202203662
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9348322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2700313103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2902-ef3b8ab93fa7ebc0ab0e2bb2f6eb31a0269a3362d8a7851578f41006c0b4974e3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSNERYfClrUlNmwy-CeJ4w3SMAylUktFW9haTnKTceXYg-1MmR2PwIoH5ElwO1URbNj4Lvydc6_OybIXBM8JxvS1sgPMKaYUs6qij7IZKSnJGS_542yGcVHkNS3EYfY0hGuMcUW5eJIdslIURFA6y35euRvlu4CWzkbvDFK2Q-db8EEP64hcjy4XF5e_vv9Yui_ppeidVoN1QYc78sxZHZ3XdkBx7d00rNHZZKLeGPgGHfo0KRt1VFFvAa0MtGmFssrsom6VQSfjOFlAFxA2zgZAb7ULYIPz4Vl20CsT4Pn9PMo-v19dLT_kp-fHJ8vFad5SgWkOPWtq1QjWKw5Ni1WDgTYN7StoGFGYVkIxVtGuVrwuScnrvkixVS1uCsELYEfZm73vZmpG6FpIISgjN16Pyu-kU1r-_WP1Wg5uKwUrakZpMnh1b-Dd1wlClKMOLRijLLgpSMoxZoQRzBL68h_02k0-pZGoqmaCc1aViZrvqda7EDz0D8cQLG8rl7eVy4fKk0DsBTfawO4_tFx8PF790f4GApW0JA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2683977365</pqid></control><display><type>article</type><title>Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Torrente‐Rodríguez, Rebeca M. ; Montero‐Calle, Ana ; San Bartolomé, Clara ; Cano, Olga ; Vázquez, Mónica ; Iglesias‐Caballero, María ; Corral‐Lugo, Andrés ; McConnell, Michael J. ; Pascal, Mariona ; Mas, Vicente ; Pingarrón, José M. ; Barderas, Rodrigo ; Campuzano, Susana</creator><creatorcontrib>Torrente‐Rodríguez, Rebeca M. ; Montero‐Calle, Ana ; San Bartolomé, Clara ; Cano, Olga ; Vázquez, Mónica ; Iglesias‐Caballero, María ; Corral‐Lugo, Andrés ; McConnell, Michael J. ; Pascal, Mariona ; Mas, Vicente ; Pingarrón, José M. ; Barderas, Rodrigo ; Campuzano, Susana</creatorcontrib><description>The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection. A multiplexed amperometric bioplatform can detect and quantify total and isotype N‐ and S‐specific anti‐SARS‐CoV‐2 serum immunoglobulins within 75 minutes. The platform was used to analyze the global and isotype‐specific immune response of COVID‐19 convalescent and vaccinated individuals, and to detect variant‐specific S antibodies from variants of concern.</description><identifier>ISSN: 0044-8249</identifier><identifier>EISSN: 1521-3757</identifier><identifier>DOI: 10.1002/ange.202203662</identifier><identifier>PMID: 35941922</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; Biosensors ; Chemistry ; Electrical measurement ; Electroanalytical Bioplatforms ; Forschungsartikel ; Hydrogen peroxide ; Immune Response ; Immune system ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin M ; Immunoglobulins ; Infections ; Interrogation ; Isotypes ; Microspheres ; Monitoring ; Multiplexing ; Nanoparticles ; Nucleocapsids ; Omicron ; SARS-Cov-2 ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Vaccines ; Viral Antigens</subject><ispartof>Angewandte Chemie, 2022-07, Vol.134 (28), p.e202203662-n/a</ispartof><rights>2022 The Authors. Angewandte Chemie published by Wiley-VCH GmbH</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2902-ef3b8ab93fa7ebc0ab0e2bb2f6eb31a0269a3362d8a7851578f41006c0b4974e3</citedby><cites>FETCH-LOGICAL-c2902-ef3b8ab93fa7ebc0ab0e2bb2f6eb31a0269a3362d8a7851578f41006c0b4974e3</cites><orcidid>0000-0003-2271-1383 ; 0000-0002-2153-172X ; 0000-0003-3539-7469 ; 0000-0002-9928-6613 ; 0000-0001-5141-0454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fange.202203662$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fange.202203662$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Torrente‐Rodríguez, Rebeca M.</creatorcontrib><creatorcontrib>Montero‐Calle, Ana</creatorcontrib><creatorcontrib>San Bartolomé, Clara</creatorcontrib><creatorcontrib>Cano, Olga</creatorcontrib><creatorcontrib>Vázquez, Mónica</creatorcontrib><creatorcontrib>Iglesias‐Caballero, María</creatorcontrib><creatorcontrib>Corral‐Lugo, Andrés</creatorcontrib><creatorcontrib>McConnell, Michael J.</creatorcontrib><creatorcontrib>Pascal, Mariona</creatorcontrib><creatorcontrib>Mas, Vicente</creatorcontrib><creatorcontrib>Pingarrón, José M.</creatorcontrib><creatorcontrib>Barderas, Rodrigo</creatorcontrib><creatorcontrib>Campuzano, Susana</creatorcontrib><title>Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors</title><title>Angewandte Chemie</title><description>The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection. A multiplexed amperometric bioplatform can detect and quantify total and isotype N‐ and S‐specific anti‐SARS‐CoV‐2 serum immunoglobulins within 75 minutes. The platform was used to analyze the global and isotype‐specific immune response of COVID‐19 convalescent and vaccinated individuals, and to detect variant‐specific S antibodies from variants of concern.</description><subject>Antibodies</subject><subject>Biosensors</subject><subject>Chemistry</subject><subject>Electrical measurement</subject><subject>Electroanalytical Bioplatforms</subject><subject>Forschungsartikel</subject><subject>Hydrogen peroxide</subject><subject>Immune Response</subject><subject>Immune system</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin M</subject><subject>Immunoglobulins</subject><subject>Infections</subject><subject>Interrogation</subject><subject>Isotypes</subject><subject>Microspheres</subject><subject>Monitoring</subject><subject>Multiplexing</subject><subject>Nanoparticles</subject><subject>Nucleocapsids</subject><subject>Omicron</subject><subject>SARS-Cov-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccines</subject><subject>Viral Antigens</subject><issn>0044-8249</issn><issn>1521-3757</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkc1u1DAUhSNERYfClrUlNmwy-CeJ4w3SMAylUktFW9haTnKTceXYg-1MmR2PwIoH5ElwO1URbNj4Lvydc6_OybIXBM8JxvS1sgPMKaYUs6qij7IZKSnJGS_542yGcVHkNS3EYfY0hGuMcUW5eJIdslIURFA6y35euRvlu4CWzkbvDFK2Q-db8EEP64hcjy4XF5e_vv9Yui_ppeidVoN1QYc78sxZHZ3XdkBx7d00rNHZZKLeGPgGHfo0KRt1VFFvAa0MtGmFssrsom6VQSfjOFlAFxA2zgZAb7ULYIPz4Vl20CsT4Pn9PMo-v19dLT_kp-fHJ8vFad5SgWkOPWtq1QjWKw5Ni1WDgTYN7StoGFGYVkIxVtGuVrwuScnrvkixVS1uCsELYEfZm73vZmpG6FpIISgjN16Pyu-kU1r-_WP1Wg5uKwUrakZpMnh1b-Dd1wlClKMOLRijLLgpSMoxZoQRzBL68h_02k0-pZGoqmaCc1aViZrvqda7EDz0D8cQLG8rl7eVy4fKk0DsBTfawO4_tFx8PF790f4GApW0JA</recordid><startdate>20220711</startdate><enddate>20220711</enddate><creator>Torrente‐Rodríguez, Rebeca M.</creator><creator>Montero‐Calle, Ana</creator><creator>San Bartolomé, Clara</creator><creator>Cano, Olga</creator><creator>Vázquez, Mónica</creator><creator>Iglesias‐Caballero, María</creator><creator>Corral‐Lugo, Andrés</creator><creator>McConnell, Michael J.</creator><creator>Pascal, Mariona</creator><creator>Mas, Vicente</creator><creator>Pingarrón, José M.</creator><creator>Barderas, Rodrigo</creator><creator>Campuzano, Susana</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2271-1383</orcidid><orcidid>https://orcid.org/0000-0002-2153-172X</orcidid><orcidid>https://orcid.org/0000-0003-3539-7469</orcidid><orcidid>https://orcid.org/0000-0002-9928-6613</orcidid><orcidid>https://orcid.org/0000-0001-5141-0454</orcidid></search><sort><creationdate>20220711</creationdate><title>Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors</title><author>Torrente‐Rodríguez, Rebeca M. ; Montero‐Calle, Ana ; San Bartolomé, Clara ; Cano, Olga ; Vázquez, Mónica ; Iglesias‐Caballero, María ; Corral‐Lugo, Andrés ; McConnell, Michael J. ; Pascal, Mariona ; Mas, Vicente ; Pingarrón, José M. ; Barderas, Rodrigo ; Campuzano, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2902-ef3b8ab93fa7ebc0ab0e2bb2f6eb31a0269a3362d8a7851578f41006c0b4974e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies</topic><topic>Biosensors</topic><topic>Chemistry</topic><topic>Electrical measurement</topic><topic>Electroanalytical Bioplatforms</topic><topic>Forschungsartikel</topic><topic>Hydrogen peroxide</topic><topic>Immune Response</topic><topic>Immune system</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin M</topic><topic>Immunoglobulins</topic><topic>Infections</topic><topic>Interrogation</topic><topic>Isotypes</topic><topic>Microspheres</topic><topic>Monitoring</topic><topic>Multiplexing</topic><topic>Nanoparticles</topic><topic>Nucleocapsids</topic><topic>Omicron</topic><topic>SARS-Cov-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccines</topic><topic>Viral Antigens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torrente‐Rodríguez, Rebeca M.</creatorcontrib><creatorcontrib>Montero‐Calle, Ana</creatorcontrib><creatorcontrib>San Bartolomé, Clara</creatorcontrib><creatorcontrib>Cano, Olga</creatorcontrib><creatorcontrib>Vázquez, Mónica</creatorcontrib><creatorcontrib>Iglesias‐Caballero, María</creatorcontrib><creatorcontrib>Corral‐Lugo, Andrés</creatorcontrib><creatorcontrib>McConnell, Michael J.</creatorcontrib><creatorcontrib>Pascal, Mariona</creatorcontrib><creatorcontrib>Mas, Vicente</creatorcontrib><creatorcontrib>Pingarrón, José M.</creatorcontrib><creatorcontrib>Barderas, Rodrigo</creatorcontrib><creatorcontrib>Campuzano, Susana</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Angewandte Chemie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torrente‐Rodríguez, Rebeca M.</au><au>Montero‐Calle, Ana</au><au>San Bartolomé, Clara</au><au>Cano, Olga</au><au>Vázquez, Mónica</au><au>Iglesias‐Caballero, María</au><au>Corral‐Lugo, Andrés</au><au>McConnell, Michael J.</au><au>Pascal, Mariona</au><au>Mas, Vicente</au><au>Pingarrón, José M.</au><au>Barderas, Rodrigo</au><au>Campuzano, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors</atitle><jtitle>Angewandte Chemie</jtitle><date>2022-07-11</date><risdate>2022</risdate><volume>134</volume><issue>28</issue><spage>e202203662</spage><epage>n/a</epage><pages>e202203662-n/a</pages><issn>0044-8249</issn><eissn>1521-3757</eissn><abstract>The development of versatile and sensitive biotools to quantify specific SARS‐CoV‐2 immunoglobulins in SARS‐CoV‐2 infected and non‐infected individuals, built on the surface of magnetic microbeads functionalized with nucleocapsid (N) and in‐house expressed recombinant spike (S) proteins is reported. Amperometric interrogation of captured N‐ and S‐specific circulating total or individual immunoglobulin (Ig) isotypes (IgG, IgM, and IgA), subsequently labelled with HRP‐conjugated secondary antibodies, was performed at disposable single or multiplexed (8×) screen‐printed electrodes using the HQ/HRP/H2O2 system. The obtained results using N and in‐house expressed S ectodomains of five SARS‐CoV‐2 variants of concern (including the latest Delta and Omicron) allow identification of vulnerable populations from those with natural or acquired immunity, monitoring of infection, evaluation of vaccine efficiency, and even identification of the variant responsible for the infection. A multiplexed amperometric bioplatform can detect and quantify total and isotype N‐ and S‐specific anti‐SARS‐CoV‐2 serum immunoglobulins within 75 minutes. The platform was used to analyze the global and isotype‐specific immune response of COVID‐19 convalescent and vaccinated individuals, and to detect variant‐specific S antibodies from variants of concern.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35941922</pmid><doi>10.1002/ange.202203662</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-2271-1383</orcidid><orcidid>https://orcid.org/0000-0002-2153-172X</orcidid><orcidid>https://orcid.org/0000-0003-3539-7469</orcidid><orcidid>https://orcid.org/0000-0002-9928-6613</orcidid><orcidid>https://orcid.org/0000-0001-5141-0454</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0044-8249
ispartof Angewandte Chemie, 2022-07, Vol.134 (28), p.e202203662-n/a
issn 0044-8249
1521-3757
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9348322
source Wiley Online Library Journals Frontfile Complete
subjects Antibodies
Biosensors
Chemistry
Electrical measurement
Electroanalytical Bioplatforms
Forschungsartikel
Hydrogen peroxide
Immune Response
Immune system
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M
Immunoglobulins
Infections
Interrogation
Isotypes
Microspheres
Monitoring
Multiplexing
Nanoparticles
Nucleocapsids
Omicron
SARS-Cov-2
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Vaccines
Viral Antigens
title Towards Control and Oversight of SARS‐CoV‐2 Diagnosis and Monitoring through Multiplexed Quantitative Electroanalytical Immune Response Biosensors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A23%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Towards%20Control%20and%20Oversight%20of%20SARS%E2%80%90CoV%E2%80%902%20Diagnosis%20and%20Monitoring%20through%20Multiplexed%20Quantitative%20Electroanalytical%20Immune%20Response%20Biosensors&rft.jtitle=Angewandte%20Chemie&rft.au=Torrente%E2%80%90Rodr%C3%ADguez,%20Rebeca%20M.&rft.date=2022-07-11&rft.volume=134&rft.issue=28&rft.spage=e202203662&rft.epage=n/a&rft.pages=e202203662-n/a&rft.issn=0044-8249&rft.eissn=1521-3757&rft_id=info:doi/10.1002/ange.202203662&rft_dat=%3Cproquest_pubme%3E2700313103%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2683977365&rft_id=info:pmid/35941922&rfr_iscdi=true